Show simple item record

dc.contributor.authorSánchez-García, Silvia
dc.contributor.authorRuiz Hornillos, Francisco Javier
dc.contributor.authorBernaola, Marta
dc.contributor.authorHabernau-Menaf, Alicia
dc.contributor.authorLasa, Eva María
dc.contributor.authorContreras, Javier
dc.contributor.authorCandón-Morillo, Rocío
dc.contributor.authorAntón Rodríguez, Cristina 
dc.contributor.authorEscudero, Carmelo
dc.date.accessioned2023-02-03T12:03:28Z
dc.date.available2023-02-03T12:03:28Z
dc.date.issued2022
dc.identifier.issn0301-0546spa
dc.identifier.urihttps://hdl.handle.net/10641/3248
dc.description.abstractBackground: The novel disease caused by the new coronavirus SARS-CoV-2 has caused an unprecedented global pandemic. Care providers of asthmatic children are increasingly con-cerned; as viral infections are one of the primary triggers of asthma flare-up. However, the effect of SARS-CoV-2 as well as the generated worldwide lockdown on asthmatic children is unknown. Objective: The aim of this study was to analyze the effects of pandemic SARS-CoV-2 in pediat-ric asthma control. Material and Methods: A retrospective, open, transversal study was performed at five ter-tiary hospitals. Recruited patients were aged <18 years and had physician-diagnosed asthma. Information regarding the 2019 and 2020 seasons were provided. Results: Data were collected from 107 children (age range: 3–18 years, mean age: 12 years). Well-controlled asthma was observed in 58 (54.2%) patients in 2020 versus 30 (28%) in 2019, and 15 (14%) patients had poorly controlled asthma in 2020 versus 28 (26.2%) in 2019. In 2020, a decrease in exacerbations caused by allergies to pollen, dust mites, molds, and through other causes not related to SARS-CoV-2 infection was observed. An increase in exacerbations was observed due to animal dander, stress, physical exercise, and SARSCoV- 2 infectionspa
dc.language.isoengspa
dc.publisherAllergologia et immunopathologiaspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectAsthma controlspa
dc.subjectAsthma severityspa
dc.subjectCOVID-19spa
dc.subjectPediatric asthmaspa
dc.subjectSARS-CoV-2spa
dc.titleEffect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma.spa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent362 KBspa
dc.identifier.doi10.15586/aei.v50i1.492spa
dc.relation.publisherversionhttps://all-imm.com/index.php/aei/article/view/492spa


Files in this item

FilesSizeFormatView
AEI_492-50-099.pdf361.5KbPDFView/Open

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España